Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer

NCT05893966 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT05893966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05893966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Recruiting
Start date
November 29, 2022
Completion date
November 29, 2032
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer